CryoPort Q2 2024 Adj. EPS $(0.29) Beats $(0.39) Estimate, Sales $57.597M Miss $57.684M Estimate
Portfolio Pulse from Benzinga Newsdesk
CryoPort (NASDAQ:CYRX) reported Q2 2024 adjusted EPS of $(0.29), beating the analyst estimate of $(0.39) by 25.64%. However, sales of $57.597 million slightly missed the estimate of $57.684 million by 0.15%. Sales increased by 1.01% compared to the same period last year.
August 06, 2024 | 9:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CryoPort's Q2 2024 adjusted EPS of $(0.29) beat estimates by 25.64%, but sales of $57.597 million missed slightly. Sales increased by 1.01% YoY.
The positive EPS surprise is likely to have a more significant impact on investor sentiment than the slight sales miss. The YoY sales increase also adds a positive note.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100